BSL-3
Laboratory Biosafety Level 3
Highly specialized BSL-3 module for isolating and handling dangerous pathogens under maximum safety conditions.
We are equipped to conduct advanced research on infectious diseases, with a proactive approach to mitigating future pandemic risks.
At Takis, we safely evaluate new molecules, vaccines, and monoclonal antibodies to protect global health.
BSL-3
Takis’ BSL-3 (Biosafety Level 3) laboratory is equipped to handle high-risk pathogens, ensuring a safe environment for research involving dangerous biological agents. Our BSL-3 lab is designed to provide the highest level of containment, supporting the development of cutting-edge therapies, including vaccines and gene therapies for infectious diseases.
The BSL-3 facility offers advanced infrastructure with HEPA filtration, negative air pressure, and stringent access controls, ensuring safety for both researchers and the environment. It is equipped with state-of-the-art equipment and technologies that enable the safe manipulation and study of pathogens under controlled conditions.
Our BSL-3 lab is dedicated in providing a controlled environment where researchers can focus on developing innovative solutions for global health challenges. With our highly trained staff and robust protocols, Takis offers a secure space for pioneering research in infectious disease, vaccine development, and therapeutic discovery.
We are committed to advancing science through the safe and efficient use of our BSL-3 facility. Whether conducting preclinical studies or advancing therapeutic applications, our BSL-3 lab plays a key role in Takis’ mission to create life-saving solutions for today’s medical needs.